JW
JWCAF.US James E Wagner Cultivation Corp
- Market cap
- USD 10.9K
- P/E
- -
- P/B
- 0.00x
- ROE
- -31.4%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Dec 2019.
Is JWCAF.US undervalued?
Graham numberThe Graham number of James E Wagner Cultivation Corp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
James E Wagner Cultivation Corp fundamental analysis
No fundamental analysis for James E Wagner Cultivation Corp yet.
James E Wagner Cultivation Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About James E Wagner Cultivation Corp
James E. Wagner Cultivation Corporation, through its subsidiary, James E. Wagner Cultivation Ltd., engages in the cultivation and sale of medical cannabis in Canada. The company focuses on producing clean, consistent cannabis using a proprietary aeroponic platform named GrowthSTORM. James E. Wagner Cultivation Corporation was founded in 2007 and is headquartered in Kitchener, Canada.
Full company profileJames E Wagner Cultivation Corp financial statements
2019 annualized: Fiscal year 2019 is not finished. Income statement and cash flow are annualized from 1 quarter up to Dec 31, 2019, the balance sheet is the latest quarter. Figures change when the annual report is published.
James E Wagner Cultivation Corp annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2019 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 0.00 | 0.00 | 57.6K | 2.13M | 946K |
| Gross Profit | -14.8K | -247K | 860K | -1.90M | 7.21M |
| Operating Income | -260K | -3.74M | -9.01M | -9.23M | -2.56M |
| EBITDA | - | - | -6.85M | -7.28M | 542K |
| Net Income | -694K | -3.63M | -10.3M | -6.99M | -4.67M |
| EPS | - | - | -0.14 | -0.07 | -0.04 |
| Balance Sheet | |||||
| Total Assets | 460K | 8.59M | 24.2M | 21.9M | 40.8M |
| Total Liabilities | 843K | 2.79M | 4.51M | 10.5M | 25.9M |
| Shareholders' Equity | -383K | 5.79M | 19.6M | 11.4M | 14.9M |
| Cash & Short-term Investments | 0.00 | 0.00 | 14.5M | 1.03M | 321K |
| Total Debt | - | - | 8.78K | 5.24M | 20.7M |
| Cash Flow | |||||
| Operating Cash Flow | -190K | -1.95M | -5.82M | -7.15M | -12.1M |
| Capital Expenditure | 223K | 575K | 4.91M | 10.9M | 1.99M |
| Free Cash Flow | - | - | -10.7M | -18.0M | -14.1M |
| Ratios | |||||
| ROE | - | -62.7% | -52.5% | -61.2% | -31.4% |
| ROA | -150.9% | -42.3% | -42.7% | -31.9% | -11.5% |
| Net Profit Margin | - | - | -17,902.4% | -327.9% | -493.1% |
| Debt to Equity | - | - | 0.00x | 0.46x | 1.39x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
James E Wagner Cultivation Corp dividends
James E Wagner Cultivation Corp has not paid dividends in the last 4 fiscal years.
Who owns James E Wagner Cultivation Corp
- Insiders 1.16%
- Institutions 0.00%
- Public & others 98.84%
- Shares outstanding 109M
- Free float 102M
James E Wagner Cultivation Corp company profile
- Company name
- James E Wagner Cultivation Corp
- Ticker
- JWCAF.US
- ISIN
- CA47031P1080
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Fiscal year end
- September
- Address
- 530 Trillium Drive, Kitchener, ON, Canada, N2R 1J4
- Phone
- 519 594-0144
- Website
- jwc.ca
About James E Wagner Cultivation Corp
James E. Wagner Cultivation Corporation, through its subsidiary, James E. Wagner Cultivation Ltd., engages in the cultivation and sale of medical cannabis in Canada. The company focuses on producing clean, consistent cannabis using a proprietary aeroponic platform named GrowthSTORM. James E. Wagner Cultivation Corporation was founded in 2007 and is headquartered in Kitchener, Canada.
James E Wagner Cultivation Corp management
8- Mr. Nathaniel WoodworthPresident & CEO
- Mr. James den OudenChief Financial Officer
- Mr. Adam WoodworthCOO, QA Supervisor & Chief Cultivator
- Ms. Krysta WoodworthChief Administrative Officer
- Ms. Laura Emma-Elizabeth FosterChief Compliance Officer & Director
- Mr. William WerthChief Technology Officer
- Mr. Daniel BexonChief Information Officer
- Eric KraushaarGeneral Counsel